291 related articles for article (PubMed ID: 19635608)
1. RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.
Widman DG; Ishikawa T; Winkelmann ER; Infante E; Bourne N; Mason PW
Vaccine; 2009 Sep; 27(41):5550-3. PubMed ID: 19635608
[TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.
Widman DG; Ishikawa T; Fayzulin R; Bourne N; Mason PW
Vaccine; 2008 May; 26(22):2762-71. PubMed ID: 18423946
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
[TBL] [Abstract][Full Text] [Related]
4. Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.
Ishikawa T; Widman DG; Bourne N; Konishi E; Mason PW
Vaccine; 2008 May; 26(22):2772-81. PubMed ID: 18433947
[TBL] [Abstract][Full Text] [Related]
5. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
[TBL] [Abstract][Full Text] [Related]
6. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
Lim CK; Takasaki T; Kotaki A; Kurane I
Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
[TBL] [Abstract][Full Text] [Related]
7. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.
Widman DG; Ishikawa T; Giavedoni LD; Hodara VL; Garza Mde L; Montalbo JA; Travassos Da Rosa AP; Tesh RB; Patterson JL; Carrion R; Bourne N; Mason PW
Am J Trop Med Hyg; 2010 Jun; 82(6):1160-7. PubMed ID: 20519618
[TBL] [Abstract][Full Text] [Related]
9. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
10. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
11. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
[TBL] [Abstract][Full Text] [Related]
12. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
Huang CY; Silengo SJ; Whiteman MC; Kinney RM
J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
[TBL] [Abstract][Full Text] [Related]
13. Equine vaccine for West Nile virus.
Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
[TBL] [Abstract][Full Text] [Related]
14. Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge.
Karaca K; Bowen R; Austgen LE; Teehee M; Siger L; Grosenbaugh D; Loosemore L; Audonnet JC; Nordgren R; Minke JM
Vaccine; 2005 May; 23(29):3808-13. PubMed ID: 15893618
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
[TBL] [Abstract][Full Text] [Related]
17. TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate.
Xia J; Winkelmann ER; Gorder SR; Mason PW; Milligan GN
J Virol; 2013 Nov; 87(22):12090-101. PubMed ID: 23986602
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.
Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K
Virol J; 2015 Apr; 12():54. PubMed ID: 25889682
[TBL] [Abstract][Full Text] [Related]
19. Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus).
Langevin SA; Arroyo J; Monath TP; Komar N
Am J Trop Med Hyg; 2003 Jul; 69(1):78-80. PubMed ID: 12932102
[TBL] [Abstract][Full Text] [Related]
20. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
